This webinar will address basic questions regarding the development of antiviral drugs and vaccines for COVID-19 and correct misinformation that has been spread. The presentation will include discussions of the process of antiviral and vaccine development, design of clinic trials, requirements for FDA approval of therapeutics, and current therapeutic initiatives.
Agenda:
Introduction | Virology of COVID-19 | Development of Antiviral Therapeutics | Vaccine Development | Clinical Trial Overview | Current Therapeutic Initiatives
Speakers:
Fred Krebs, Ph.D.
Professor, Microbiology & Immunology
Director, Infectious Disease Program
Co-Director, Division of Interdisciplinary and Career-Oriented Programs
Paul McGonigle, Ph.D.
Professor, Pharmacology & Physiology
Director, Drug Discovery & Development
Co-Director, Division of Interdisciplinary and Career-Oriented Programs
Sonia Navas-Martin, Ph.D.
Associate Professor, Microbiology & Immunology
Michele Kutzler, Ph.D.
Associate Professor, Medicine, Microbiology & Immunology
Associate Dean for Faculty Affairs
Richard Mangano, Ph.D.
Associate Professor Director, Clinical Research Program |
